BIOPROCANN

BIOPROCANN S.A. is a Greek medical cannabis company that made history in 2018 by receiving the first-ever production license for medicinal cannabis issued by the Greek government. The company operates a state-of-the-art 48,000-square-meter cultivation and processing facility located in Corinth, Greece, designed to meet rigorous international pharmaceutical standards. BIOPROCANN focuses on the precision cultivation of high-quality cannabis strains to produce pharmaceutical-grade dried flowers and extracts. Its primary business model involves supplying medical cannabis to domestic and international markets, specifically targeting the UK and Germany. The company's products are intended to treat a variety of conditions, including chronic pain, neuropathic pain, and chemotherapy-induced nausea.